Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,160,547 | 2,244,000 | 2,529,000 | 1,526,000 | 960,960 |
| Marketable Securities | 2,816,908 | 1,493,000 | 1,452,000 | 1,460,000 | 2,489,760 |
| Inventories | 2,191,276 | 2,264,000 | 2,133,000 | 2,110,000 | 2,106,160 |
| Income taxes - deferred | 1,536,448 | N/A | N/A | N/A | 1,439,200 |
| Other current assets | 4,905,998 | 4,391,000 | 4,676,000 | 4,646,000 | 4,916,240 |
| TOTAL | $13,626,786 | $10,392,000 | $10,790,000 | $9,742,000 | $12,608,400 |
| Non-Current Assets | |||||
| PPE Net | 6,467,992 | 8,835,000 | 8,531,000 | 8,283,000 | 6,433,280 |
| Intangibles | 2,141,226 | 2,648,000 | 2,324,000 | 2,308,000 | 1,837,360 |
| Other Non-Current Assets | 332,106 | 539,000 | 536,000 | 476,000 | 3,064,880 |
| TOTAL | $8,941,324 | $12,022,000 | $11,391,000 | $11,067,000 | $11,335,520 |
| Total Assets | $22,568,110 | $22,414,000 | $22,181,000 | $20,809,000 | $23,943,920 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,581,285 | 1,157,000 | 1,096,000 | 1,394,000 | 1,449,840 |
| Accounts payable and accrued liabilities | 706,443 | 4,173,000 | 3,917,000 | 7,306,000 | 684,880 |
| Other current liabilities | 3,322,106 | N/A | 996,000 | N/A | 3,333,680 |
| TOTAL | $8,718,182 | $7,012,000 | $7,816,000 | $8,700,000 | $8,585,360 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,378,903 | 4,971,000 | 4,908,000 | 3,595,000 | 3,646,160 |
| Other Non-Current Liabilities | 2,994,692 | 1,491,000 | 505,000 | 3,667,000 | 2,513,840 |
| TOTAL | $7,650,437 | $6,867,000 | $5,732,000 | $7,518,000 | $6,904,240 |
| Total Liabilities | $16,368,619 | $13,879,000 | $13,548,000 | $16,218,000 | $15,489,600 |
| Shareholders' Equity | |||||
| Common Shares | 1,483,269 | 1,484,000 | 1,483,000 | 1,484,000 | 1,485,120 |
| Retained earnings | 4,778,786 | 3,887,000 | 4,137,000 | 3,317,000 | 4,038,720 |
| Other shareholders' equity | -643,358 | -702,000 | -721,000 | -739,000 | 1,922,480 |
| TOTAL | $5,922,650 | $4,957,000 | $5,178,000 | $4,335,000 | $7,710,080 |
| Total Liabilities And Equity | $22,291,268 | $18,836,000 | $18,726,000 | $20,553,000 | $23,199,680 |